Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Vasc Surg. 2016 Dec 24;65(3):783–792.e4. doi: 10.1016/j.jvs.2016.09.054

Appendix Table III.

AVF prevalence (Intermediate Models)

Model 1a Model 2b
AVF
Prevalencec 		P-value
compared
to White		 AVF
Prevalencec 		P-value
compared
to White
white 79.5% ref 78.7% ref
black 63.5% <0.001 64.1% <0.001
asian/PI 68.6% <0.001 70.5% <0.001
hispanic 74.8% <0.001 78.4% 0.80
a

Adjusted for age and its square, sex, index year, index month, total covered charges from outpatient, inpatient and carrier files in the year preceding index fistula/graft creation date, inpatient setting for the index fistula/graft creation and all co-morbidities available from the Chronic Condition Data Warehouse (except chronic kidney disease)

b

Adjusted for age and its square, sex, index year, index month, total covered charges from outpatient, inpatient and carrier files in the year preceding index fistula/graft creation date, inpatient setting for the index fistula/graft creation, all co-morbidities available from the Chronic Condition Data Warehouse (except chronic kidney disease) and community contextual factors

c

Predictive margin for prevalence of fistula created vs graft.